Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alimera Sciences Inc (NQ: ALIM ) 5.540 UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Alimera Sciences Inc < Previous 1 2 3 Next > The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug October 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 04, 2021 Gainers Progenity (NASDAQ:PROG) stock moved upwards by 18.43% to $2.12 during Monday's regular session. Trading volume for this security as of 12:30 EST is 91.5... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 23, 2021 Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 EST, Vivos Therapeutics's stock is trading at a... Via Benzinga The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More October 24, 2021 Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... Via Benzinga Exposures Product Safety Alimera Sciences, inc (ALIM) Q2 2021 Earnings Call Transcript August 13, 2021 ALIM earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Recap: Alimera Sciences Q2 Earnings August 13, 2021 Shares of Alimera Sciences (NASDAQ:ALIM) moved higher by 5.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 252.94%... Via Benzinga 60 Biggest Movers From Yesterday August 17, 2021 Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of... Via Benzinga Earnings Scheduled For August 13, 2021 August 13, 2021 Companies Reporting Before The Bell • Jaguar Health (NASDAQ:JAGX) is expected to report quarterly loss at $0.03 per share on revenue of $7.28 million. • Fangdd... Via Benzinga The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO August 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety How Does Alimera Sciences's Debt Look? August 11, 2021 Over the past three months, shares of Alimera Sciences (NASDAQ:ALIM) fell by 3.92%. Before we understand the importance of debt, let us look at how much debt Alimera... Via Benzinga 35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021 May 27, 2021 RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be... From MicroCap Rodeo Via AccessWire Alimera Sciences Inc (ALIM) Q1 2021 Earnings Call Transcript April 29, 2021 ALIM earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx April 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... Via Benzinga Recap: Alimera Sciences Q1 Earnings April 28, 2021 Shares of Alimera Sciences (NASDAQ:ALIM) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 162.50% over the... Via Benzinga The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping April 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... Via Benzinga Exposures Product Safety Week In Review: Sinopharm Transfers $4.6 Billion In Assets, Including Two COVID-19 Vaccines April 17, 2021 Sinopharm Group will transfer six of its vaccine companies to Beijing Tiantan Biological Products. Two of the transferring companies have approved COVID-19 vaccines, and Sinopharma said a public... Via Talk Markets Exposures COVID-19 The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx April 24, 2021 Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... Via Benzinga Exposures Product Safety 10 Biggest Price Target Changes For Thursday April 15, 2021 Raymond James lifted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $750. NVIDIA shares rose 1.9% to $622.39 in pre-market trading. Barclays raised the price target... Via Benzinga Alimera, Ocumension Ink Licensing Pact For Fluocinolone Acetonide Eye Implant In China April 14, 2021 Ocumension Therapeutics has inked an exclusive license agreement for Alimera Sciences Inc's (NASDAQ: ALIM) 0.19mg fluocinolone acetonide... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.